BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Clinical trial NCT04136470 · UNKNOWN

Trial details

NCT number: NCT04136470
Sponsor: Ardigen
Status: UNKNOWN
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Microbiome Metagenome Immunotherapy Melanoma

Start date: 2019-04-01
Primary completion: 2020-09-30
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.